X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE ABBOTT INDIA TTK HEALTHCARE/
ABBOTT INDIA
 
P/E (TTM) x 18.4 38.5 47.8% View Chart
P/BV x 2.2 10.0 21.8% View Chart
Dividend Yield % 0.8 0.7 110.9%  

Financials

 TTK HEALTHCARE   ABBOTT INDIA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-18
ABBOTT INDIA
Mar-18
TTK HEALTHCARE/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,4586,110 23.9%   
Low Rs7953,996 19.9%   
Sales per share (Unadj.) Rs408.71,552.2 26.3%  
Earnings per share (Unadj.) Rs12.9188.8 6.8%  
Cash flow per share (Unadj.) Rs23.6196.4 12.0%  
Dividends per share (Unadj.) Rs5.0055.00 9.1%  
Dividend yield (eoy) %0.41.1 40.8%  
Book value per share (Unadj.) Rs164.9796.6 20.7%  
Shares outstanding (eoy) m14.1321.25 66.5%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.83.3 84.7%   
Avg P/E ratio x87.626.8 327.3%  
P/CF ratio (eoy) x47.625.7 185.2%  
Price / Book Value ratio x6.86.3 107.7%  
Dividend payout %38.929.1 133.5%   
Avg Mkt Cap Rs m15,916107,376 14.8%   
No. of employees `0002.23.3 67.5%   
Total wages/salary Rs m1,0903,937 27.7%   
Avg. sales/employee Rs Th2,573.89,929.3 25.9%   
Avg. wages/employee Rs Th485.71,185.1 41.0%   
Avg. net profit/employee Rs Th81.01,207.7 6.7%   
INCOME DATA
Net Sales Rs m5,77632,985 17.5%  
Other income Rs m761,170 6.5%   
Total revenues Rs m5,85134,155 17.1%   
Gross profit Rs m4265,245 8.1%  
Depreciation Rs m152162 94.1%   
Interest Rs m4738 123.8%   
Profit before tax Rs m3026,215 4.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1202,203 5.4%   
Profit after tax Rs m1824,012 4.5%  
Gross profit margin %7.415.9 46.3%  
Effective tax rate %39.735.4 112.1%   
Net profit margin %3.112.2 25.9%  
BALANCE SHEET DATA
Current assets Rs m2,55622,655 11.3%   
Current liabilities Rs m1,6756,681 25.1%   
Net working cap to sales %15.348.4 31.5%  
Current ratio x1.53.4 45.0%  
Inventory Days Days3365 51.6%  
Debtors Days Days3529 120.0%  
Net fixed assets Rs m1,103835 132.0%   
Share capital Rs m141213 66.5%   
"Free" reserves Rs m2,18816,715 13.1%   
Net worth Rs m2,33016,928 13.8%   
Long term debt Rs m70-   
Total assets Rs m4,07324,162 16.9%  
Interest coverage x7.4163.7 4.5%   
Debt to equity ratio x00-  
Sales to assets ratio x1.41.4 103.9%   
Return on assets %5.616.8 33.5%  
Return on equity %7.823.7 32.9%  
Return on capital %14.936.9 40.4%  
Exports to sales %3.00-   
Imports to sales %0.60-   
Exports (fob) Rs m172NA-   
Imports (cif) Rs m35NA-   
Fx inflow Rs m172369 46.7%   
Fx outflow Rs m553,807 1.4%   
Net fx Rs m117-3,438 -3.4%   
CASH FLOW
From Operations Rs m2531,527 16.6%  
From Investments Rs m-226-2,148 10.5%  
From Financial Activity Rs m-72-1,024 7.0%  
Net Cashflow Rs m-41-1,646 2.5%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 3.7 7.9 46.8%  
FIIs % 5.2 0.1 5,200.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 17.1 150.9%  
Shareholders   12,723 18,270 69.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   SHASUN PHARMA  WYETH LTD  TORRENT PHARMA  ALEMBIC LTD  DR. REDDYS LAB  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Modi's Victory Creates Sensex History; Ache Din Ahead?(Podcast)

Throughout the week, one slogan that took over the market and country as a whole was, Ab ki baar phir Modi Sarkar.

Related Views on News

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

What Makes TVS Srichakra and CCL Products a Cut Above the Rest?(The 5 Minute Wrapup)

May 17, 2019

Despite the commodity nature of their businesses, these two stocks have rewarded shareholders well.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


May 23, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - J.B.CHEMICALS COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS